The Human TNFSF8 / CD30 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between TNFSF8 and its receptor CD30 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.
Form:
96-well Microplate
Samples:
Plasma, Serum, Antibodies, Proteins, Small Molecules, Peptides
Target:
CD30 (TNFRSF8), CD30 Ligand (TNFSF8 / CD30L)
Application Notes:
Colorimetric
* VAT and and shipping costs not included. Errors and price changes excepted
